<DOC>
	<DOCNO>NCT01313910</DOCNO>
	<brief_summary>The purpose study see ImmunoLin速 reduce frequency bowel movement gastrointestinal ( GI ) symptoms HIV volunteer persistent GI symptom . The study also examine effect ImmunoLin速 bacteria gut immune system gut tissue well blood .</brief_summary>
	<brief_title>CCRC : A Project Treatment HIV Enteropathy With ImmunoLin速 Supplements</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>HIV Enteropathy</mesh_term>
	<criteria>GI complaint consist least 2 loose watery stool per day mark abdominal bloating adversely effect activity daily live ( ADLs ) common social functioning great 6 month , even though symptomatology may wax wane time period . Subjects routine test exclude enteric pathogen . Subjects make effort identify food intolerance , especially lactose intolerance . Symptoms believe independent ART medication know potential cause similar GI complaint ; either symptom predate initiation medication shift different option ART appreciable effect symptom . Over previous 6 month , alcohol use characterize occasional less 1.5 ounce per day maximum estimate use ( &lt; 2 beer glass wine 1 drink hard liquor ) . Subjects great 18 year age . Plasma HIV load suppress less 400 cp/mL least four month , restriction peripheral CD4+ Tcell count . Blips &lt; 1000 cp/mL allow , provide associated medication interruption pVL undetectable observed blip . Subjects willing maintain food GIsymptom diary receive ImmunoLin速 supplement . Subjects willing attempt maintain stable regimen ART duration study unless indicate patient safety . Subjects free antibiotic use least 3weeks prior study entry except chronic antibiotic use prophylaxis accord SOC HIV management . Usage antibiotic course study assess case case basis study team . Subjects must free condition require chronic therapy know alter gut flora . Steroid use must limit intermittent topical preparation include inhaled dermatologic route application . know unrelated cause GI abnormality . abnormal coagulation parameter ( PT &gt; 1.2 ULN ) thrombocytopenia ( platelet count &lt; 50,000 within 6 week ) contraindication upper endoscopy conscious sedation anemia ( &gt; grade 1 [ appendix D ] ) aspirin , ibuprofen , warfarin agent interfere coagulation cascade prohibit within 1 week endoscopy . positive pregnancy test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>diarrhea</keyword>
</DOC>